Pasithea to Develop Vaccine to Train Immune System & Participating in MS Clinical Trials

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Pasithea Therapeutics, working with Hooke labs, wants to develop a "tolerizing" vaccine that will train the immune system and protect myelin; and reads the column by John Connor, Fall Down, Get Up Again, “At 64, I’m Surprised to Be Scrambling to Mount a Chariot”.

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/